Botulism remains one of the most economically devastating diseases affecting grazing cattle herds across northern Australia.
The disease, caused by neurotoxins produced by Clostridium botulinum types C and D, leads to paralysis and death with losses often going unnoticed. 1
The current botulism vaccine formulations provide protection with a single dose thanks to advanced vaccine formulations.
Among them, Longrange stands out for its single annual dose effectiveness, validated field performance, and superior safety profile.
Why is botulism such a risk?
Clostridium botulinum spores are widespread in Australian soils, but disease has historically been linked to phosphorus deficient soils.
However, protein deficiency is also associated with botulism and occurs seasonally across much of northern Australia, regardless of soil type as tropical grasses hay off during the dry season and during periods of drought.
In an attempt to correct these nutritional imbalances, cattle chew bones and hides, exposing them to potent type C and D neurotoxins which are produced by botulism spores which grow in the carcasses of dead animals.
These potent toxins block nerve impulses, resulting in flaccid paralysis and death, although some affected cattle will survive but suffer from poor productivity as their ability to forage is reduced. 1
The extensive nature of northern production systems mean that the tell-tale signs of botulism are often not seen, with most cases occurring unnoticed away from waters; cattle simply “go missing”.
Herd losses up to 25 per cent and annual death rates between 10 and 20 per cent in severely affected groups are well documented.
There is no specific treatment; control relies entirely on prevention. 1
Vaccination – the only effective management tool
Preventing botulism demands consistent, high-level, herd-wide immunity.
Incomplete musters can leave 5–20 per cent of animals unvaccinated and vulnerable. 2
Longrange is a bivalent vaccine designed for annual administration, conferring immunity within 28 days post-injection, with persistence of protective antibody titres for at least 12 months.
Longrange delivers up to 50-fold greater protection than required for protection from challenge. 3
Evidence of effectiveness
A three-year field trial, funded by Meat & Livestock Australia and conducted by government researchers, administered Longrange annually to 1,525 replacement heifers. 4
Over this time, Longrange vaccinated cattle had mortality rates 50 per cent lower than unvaccinated control animals run with them in the same paddocks. The control group (n=486) had a 14 per cent mortality rate, while the vaccinated group (n=1,039) had only 7 per cent mortality from all causes.
The study was done in heifers and the study period included their first calving season, when calving related losses often occur. For a herd of 1,500, vaccination returns a net benefit of $150,750, equating to a cost benefit ratio of $23.30 per $1 dollar spent.
This data supports laboratory testing data which demonstrates toxin neutralizing antibody titres that last for at least 12 months following initial vaccination, aligning with field evidence of persistent protection. 5
Safety and herd integration
Longrange is formulated as a water-based vaccine, minimising site reactions such as granulomas and carcase trim compared to oil-based alternatives. Controlled studies report that cattle vaccinated with Longrange have over three times fewer large site reactions compared to SingVac, the competing oil-based vaccine. 6
Minimizing these reactions not only improves welfare but also maximizes carcase value.
Integration with herd health management is straightforward.
Longrange can be administered alongside other vaccines for reproductive and clostridial diseases (e.g., Vibrovax for Vibriosis and Pestigard for pestivirus ), facilitating comprehensive protection in one management event.
Immunological rationale for annual boosters
Research shows immunological maturity in cattle may not occur until as late as puberty 7, meaning first-year boosters for heifer calves first vaccinated at weaning are critical to establishing lasting protection in replacement breeding females.
This is especially relevant for replacement heifers immediately post- calving, when risk of botulism surges due to nutritional stress brought on by lactation.
Annual vaccination also ensures high maternal antibody transfer from dams to calves, preventing neonatal losses from botulism until the calves themselves can be immunized.
Comparative efficacy and industry recommendations
Annual vaccination avoids the pitfalls of multi-year interval s between vaccinations and complex programs, which can compromise protection due to missed musters, inaccurate records or inadequate immune responses.
Longrange was developed specifically for Australian conditions, is suitable for organic systems, and contains no GMOs—adding further assurance for modern sustainable production operations.
Conclusion
An annual approach to botulism prevention is essential for sustainable cattle production in high-risk areas.
Longrange provides rapid, robust, and persistent immunity with minimal adverse effects, backed by large-scale field trials and robust testing.
Annual vaccination of your herd with Longrange is not only scientifically justified—it is economically prudent and logistically efficient, safeguarding the future of your beef production.
References:
1. Anon. Agnote K29. Botulism Poisoning in Cattle in the Northern Territory, February 2022.
2. McCosker T.H, and Eggington A.R Cattle Mustering Efficiency Using Helicopters in a Monsoonal Savanna Woodland. Aust Ranger J. 1986: 8(2): 91-96.
3. Zoetis Data on File.
4. Smith PC et al., Industry initiatives to improve young breeder performance in the Pilbara and Kimberley of W.A, NBP.345, Meat and Livestock Australia, North Sydney, 2010, 28-29.
5. Zoetis Data on File.
6. Zoetis Data on File.
7. Chase CC, Hurley DJ, Reber AJ. Neonatal immune development in the calf and its impact on vaccine response. Vet Clin North Am Food Anim Pract. 2008 Mar;24(1):87-104.
